Introduction Healthcare inequality remains a significant challenge, affecting treatment access and clinical outcomes for various patient groups. In rheumatoid arthritis (RA), disparities in the initiation of biological and targeted synthetic…

Introduction High-throughput technologies have revolutionized the understanding of rheumatoid arthritis (RA), revealing new molecular and cellular pathways in tissue inflammation. Fibroblasts, long studied in RA, have gained renewed attention as…